The cost to develop a new drug and win FDA marketing approval is now pegged at nearly $2.6 billion, according to a new report from the Tufts Center for the Study of Drug Development. The figure includes two basic components – the average amount of money that is actually spent is $1.395 billion. Then there are opportunity costs of $1.16 billion.. Drug makers contend development is increasingly expensive due to rising costs. But consumer groups argue such estimates unfairly mask irrelevant and overstated expenses, and maintain the estimate is overstated. “If you believe that, you probably also believe the earth is flat,” says Rohit Malpani, director of policy and analysis at Doctors Without Borders.. �